Philip Morris and Altria race to capture surging nicotine pouch market led by Zyn
Nicotine pouch demand, led by brands like Zyn, is surging, prompting tobacco giants to expand production and market share. This trend presents a growth opportunity for traditional tobacco companies, even as health warnings about addiction persist.
The story
The market for nicotine pouches, epitomized by the surging popularity of Zyn, is experiencing explosive growth, driving major tobacco companies to ramp up production and expand their presence. Swedish Match, acquired by Philip Morris International (PM) in 2022, is a key player with its Zyn brand, while Altria (MO) is also making significant moves to capitalize on this trend.
This growth comes amidst a backdrop of social media influencers promoting these products, often suggesting health benefits compared to traditional tobacco, though health experts caution about their highly addictive nature. The market expansion reflects a broader shift in consumer preferences towards smoke-free nicotine alternatives.
For companies like PM and MO, this represents a crucial avenue for revenue growth as traditional cigarette sales decline. PM's acquisition of Swedish Match was a strategic move to dominate this category, and Altria is investing heavily to compete. The ongoing debate around health implications and potential regulatory scrutiny remains a key overhang, but for now, the focus is on meeting escalating demand and capturing market share.
The second-order setup involves how effectively these companies can scale production and marketing while navigating potential regulatory headwinds. The tension lies between the significant growth opportunity and the inherent risks associated with nicotine products and potential public health backlash.
Our read · Mon, Jul 6
With Zyn's popularity driving a nicotine pouch boom, the question for Altria (MO) and Philip Morris (PM) is how effectively they can capitalize on this growth to offset declines in traditional tobacco sales.
Why. The narrative highlights a significant growth vector for major tobacco players like PM, which owns Zyn, and MO, who are racing to meet demand. PM's revenue growth of +7.3% YoY already reflects this shift, offering a clear path to continued expansion in a category with high margins.
Both cases
What could change this view: Increased regulatory scrutiny or adverse public health campaigns specifically targeting nicotine pouches could severely impact demand and profitability.
Who reported it · 1
Keep reading
More on PM
FDA authorizes 11 ZYN Ultra nicotine pouches for Philip MorrisEfforts to Help Smokers Quit Stall Under TrumpLatest on the Wire
BlackRock bitcoin ETF posts $541.1 million outflow as tech sell-off spreadsPoland says Russian missiles and drone crashed during Ukraine assaultAnthropic debut fails to halt technology-led slide in US stocksUS MATCH Act puts ASML at center of China chip export disputeBeijing plans to bar young red-chip firms from overseas listingsContinue on the Wire →Latest on the Wire
German producer prices jump 8.1% in October as industrial inflation acceleratesChina seeks protections to restart US private-equity investmentsAMD shares fall 11% after Hunterbrook warns over China linksAnthropic IPO could become the largest in US history on ThursdayContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangBitcoin nears $64,000 as Anthropic IPO lifts Nasdaq futures nearly 2%About this report
Reported by NYT Business as Zyn’s Popularity Has Tobacco Companies Racing to Cash In
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →